Genetics of APL and the molecular basis of retinoic acid treatment

Int J Cancer. 1997 Feb 7;70(4):473-4. doi: 10.1002/(sici)1097-0215(19970207)70:4<473::aid-ijc17>3.0.co;2-g.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Down-Regulation
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / genetics*
  • Leukemia, Promyelocytic, Acute / metabolism
  • Neoplasm Proteins / genetics*
  • Nuclear Proteins*
  • Oncogene Proteins, Fusion / genetics*
  • Receptors, Retinoic Acid / genetics*
  • Transcription Factors / metabolism*
  • Tretinoin / therapeutic use
  • Tumor Cells, Cultured
  • Tumor Suppressor Proteins

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins
  • Nuclear Proteins
  • Oncogene Proteins, Fusion
  • Receptors, Retinoic Acid
  • Transcription Factors
  • Tumor Suppressor Proteins
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • Tretinoin